Abstract
Patient education in atopic dermatitis (AD) has worked in parallel to the gold standard of pharmacological treatment as a foundational component of therapeutic regimens. In addition to improving patient education, past investigations of educational interventions have demonstrated profound reductions in disease severity for patients living with AD. However, prior meta-analytical work has focused mostly on comparing in-person interventions, and thus the need to determine the effectiveness of virtual methodologies in the current post-COVID era remains. In this study, we conducted a systematic review of the literature to determine the effectiveness of online programming in AD education compared to in-person interventions. A comprehensive search was conducted in accordance with the Cochrane Handbook for Systematic Reviews of Interventions 2019. Studies were retrieved based on articles published up to 04 April 2023. Adherence to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) Statement guided the reportage process for this systematic review and meta-analysis. The primary outcome of our meta-analysis was the effect of various educational modalities on atopic dermatitis severity as measured by multiple scales across the studies, the most common including SCORAD, Dermatology Life Quality Index (DLQI), Patient Oriented Eczema Measure (POEM), and Eczema Area and Severity Index (EASI). Most studies were randomized controlled trials, primarily from North America and Western Europe and focused on patient and/or caregiver education about disease management, self-care techniques, avoidance of triggers, and comprehensive understanding of the disease process. Our pooled analyses showed that targeted educational programs in understudied adult populations can be as impactful as those in pediatric groups. Moreover, virtual interventions can be employed as constructive tools for reducing barriers of access to patient education. Future research on educational interventions should utilize various methodologies to encourage individual learning preferences with a focus on adult cohorts.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Atopic dermatitis (AD) is a chronic inflammatory skin disease with a very pronounced and detrimental impact on a patient’s quality of life. While the combination of topical and systematic treatments (e.g. corticosteroids, JAK-inhibitors, biologics) dependent on disease severity has been the gold standard of pharmacological interventions, patient education has worked in parallel as a foundational component of treatment regimens.
One of the earliest examples of successful educational programming can be seen in Germany, with the creation of ‘eczema academies’ in the 1990s deploying structured interventional sessions with modules based on general information about AD, practical advice for treatment of affected skin, education on triggers for flares, and discussion of the role of mental health in the disease. In the United States, the first eczema school was founded in 2014 with similar success at incorporating patient education to reduce disease severity and symptoms [1]. In addition to increases in patient education, prior studies of educational interventions have demonstrated a direct impact in reducing disease severity for pediatric patients living with AD [2].
However, prior meta-analytical work has focused mostly on comparing in-person interventions. Considering the large rise in virtual telehealth in the post-COVID era, we conducted a systematic review of the literature to determine the effectiveness of online programming in AD education compared to in-person interventions.
Methodology
Data source
A comprehensive search was conducted in accordance with the Cochrane Handbook for Systematic Reviews of Interventions 2019 [3]. The following databases were searched for articles on April 04, 2023, with no restriction imposed on publication date: PubMed, MEDLINE, CINAHL, Web of Sciences, Ovid Databases (e.g. Medline, Embase, Emcare). The inclusion and exclusion criteria were organized according to Population, Intervention, Comparison, Outcome, and Study (PICOS) criteria. Inclusion criteria: any age or gender patient with a diagnosis of atopic dermatitis (AD) and/or any parent/caregiver of a patient with a diagnosis of atopic dermatitis; any intervention with an educational focus aimed at improving health knowledge and decreasing severity of AD; with or without a comparator; primary outcomes include outcomes such as SCORing Atopic Dermatitis (SCORAD). Study design is limited to interventional studies in humans, published in English language in peer-reviewed journals. Exclusion criteria: no report of any primary outcome with raw data; secondary research (review or meta-analysis); gray literature (dissertation, conference abstract, letter, review, commentary, editorial, note); language other than English. No language or date restrictions were applied.
Study selection
Studies were retrieved based on articles published up to 04 April 2023 with the intention of selecting for articles incorporating educational interventions for patients and/or caregivers of patients living with atopic dermatitis.
Adherence to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) Statement guided the reportage process for this systematic review and meta-analysis. After the removal of duplicate entries, the resultant articles were independently scrutinized for suitability by two independent authors using Covidence systematic review software. Initial screening involved assessing article abstracts to determine their relevance to the study criteria. If an abstract did not provide enough information for a conclusive decision, a full-text review was undertaken to ascertain its eligibility. After independent screening, the two authors compared their findings. Any discrepancies in the selection of studies were resolved through discussion or, if necessary, by consulting a third, impartial investigator. This rigorous process was implemented to minimize bias and ensure the validity of study selection. The following information was recorded: authors, year of publication, country, study design, sample size, characteristics of participants (age, gender), educational modalities used, outcome measures, and key findings. The search diagram is summarized in Fig. 1.
Primary outcome
The primary outcome of our meta-analysis was the effect of various educational modalities on atopic dermatitis severity. This outcome was evaluated using multiple scales across the studies, among the most common including SCORAD, Dermatology Life Quality Index (DLQI), Patient Oriented Eczema Measure (POEM), and Eczema Area and Severity Index (EASI).
SCORAD is a well-regarded tool for quantifying patients’ the severity of disease by categorizing a point system respective to extent of lesions, itch, and sleep quality of life among others. The DLQI scoring scale is a commonly used measure to assess the extent of disease severity among different skin conditions with categories focused on disease severity and patient quality of life. The POEM scale is another AD-specific severity scale with a focus on subjective patient and/or caregiver reported measures.
Given the variety of scales used in the included studies, a direct, uniform comparison of disease intensity was not possible. However, each scale contributes unique insights into the experience and severity of atopic dermatitis severity. This rich array of measurements allowed for a more comprehensive understanding of disease intensity and the effectiveness of various interventions.
The results from each study were converted to a common effect size metric to facilitate comparison. Each scale’s relative strengths and possible limitations were considered during data interpretation. As such, our primary outcome analysis not only encompasses a broad overview of the treatment effectiveness but also captures the multidimensional nature of itch as experienced by patients.
Quality assessment
The quality of included studies was evaluated using the Cochrane Risk of Bias Assessment tool. This tool evaluates the risk of bias in clinical studies based on various domains. Any disagreements between the two authors in the quality assessment were resolved by discussion or by involving a third author.
Statistical analysis
Statistical analyses were performed using Review Manager 5.4.1 (Cochrane Collaboration). Heterogeneity among studies was quantified using the I2 statistic, τ2 and the χ2 statistic. Studies were regarded as homogenous if I2 ≤ 40%, in which case a fixed effect model of meta-analysis was utilized. If I2 > 40%, a random effect model was used. Subgroup analysis was conducted based on the different treatment modalities. Sensitivity analysis was performed by sequentially omitting each study to assess the robustness of the results. Publication bias was evaluated visually with a funnel plot and statistically with Egger’s regression test.
Results
The present systematic review and meta-analysis synthesizes findings from a total of eighteen studies, representing a comprehensive pool of 3,234 study subjects, with 1,597 in the active arm. From our research, this is the first meta-analysis investigating the efficacy of online educational interventions for the management of atopic dermatitis as compared to traditional in-person interventions.
Study characteristics
The included studies encompassed a wide range of educational interventions for atopic dermatitis, providing a diverse and multifaceted data pool. The methodologies, population demographics, and AD outcome scales varied among studies, offering a nuanced and thorough investigation of the phenomenon that can be seen in Table 1. Most studies were randomized controlled trials, primarily from North America and Western Europe. Most interventions were focused on patient and/or caregiver education about disease management, self-care techniques, avoidance of triggers, and comprehensive understanding of the disease process. Some studies also incorporated psychological support or group discussions to foster emotional well-being and collective problem-solving. The age of study participants ranged from infancy to adulthood, with a substantial portion of studies focusing on pediatric populations (mean age 7.15; range 2.40-34.53).
Outcome assessment
Outcome assessment was predominantly conducted using the SCORAD index, although several studies employed alternative or additional measures such as the EASI, POEM, and DLQI.
SCORAD index
Twelve of the studies used the SCORAD index as their primary outcome measure. A summary of the effects of the various educational programs on the SCORAD index across these studies indicated a significant reduction in the SCORAD index in the intervention group compared to the control group (standard mean difference [SMD] = 0.65, 95% Confidence Intervals (CI): 0.45–0.86), P < 0.00001). High heterogeneity was observed among the studies (I2 = 81%). The pooled effect can be observed in Fig. 2.
QOL
Among the studies assessed, seven assessed the quality of life as an outcome measure, using various indices (CDLQI, FDLQI, and IDQOL, DLQI, CHU-9D, Skindex-29). The meta-analysis of these studies revealed a significant pooled SMD of 0.36 (95% CI: 0.18–0.54, P = 0.0002), with high heterogeneity between the studies (I2 = 54%). The pooled effect can be observed in Fig. 3.
POEM
The POEM score was reported as outcome measure in four studies. These studies reported a significant reduction in the POEM score in the intervention group (SMD = 0.28, 95% CI: 0.07–0.49, P = 0.009). Moderate heterogeneity was observed between these studies these (I2 = 47%). The pooled effect can be observed in Fig. 4.
EASI
EASI measurements were employed in only three studies. All three studies reported a significant reduction in EASI scores in the intervention group compared to the control group. The pooled mean difference was 0.80 (95% CI: 0.54–1.06, P < 0.00001), with low heterogeneity between the studies (I2 = 0%). The pooled effect can be observed in Fig. 5.
Subgroup analyses
Subgroup analyses were conducted based on the mode of educational intervention, contrasting virtual and in-person methods. Due to the limited number of studies using virtual methods, the POEM score was utilized for this comparison as it was the most reported measure in these studies. The results demonstrated a beneficial effect of both in-person and virtual educational programs on atopic dermatitis management. However, the reduction in POEM scores in the virtual intervention group was not statistically significant as shown in Fig. 6.
When performing subgroup analyses based on the age of the patient populations, groups were differentiated between adult and pediatric populations. Both demographics showed beneficial reductions in the SCORAD index following the educational interventions. However, the applicability of these findings to the adult population is limited, as only one study focused on this demographic (Fig. 7).
Heterogeneity and sensitivity analysis
Our analysis showed varying levels of heterogeneity among the different outcome measures. The high level of heterogeneity in the SCORAD index and DLQI score could be attributed to several factors including study design, measurement protocols, sample size, participant characteristics, duration of follow-up, and type of educational interventions. In contrast, the POEM score and EASI measurements showed lower levels of heterogeneity suggesting a higher level of consistency among these studies.
To evaluate the robustness of our results, a sensitivity analysis was conducted. Each study was excluded one at a time to evaluate its influence on the overall effect size. The overall effect size remained consistent and did not show significant variation, thereby attesting to the stability of the findings.
Publication bias
Publication bias was assessed by generating funnel plots for each of the four primary outcome measures. The funnel plots for DLQI score, POEM score, EASI measurements, and SCORAD index can be seen in Figs. 8, 9 and 10, and Fig. 11, respectively. Visual inspection of these funnel plots did not suggest any clear asymmetry, indicating the absence of notable publication bias for these outcomes. Moreover, the Egger’s regression test provided statistical evidence supporting this visual interpretation. The p-values for the Egger’s test for the SCORAD index, DLQI score, POEM score, and EASI measurements were 0.0677, 0.2718, 0.4676, and 0.312, respectively, suggesting a lack of significant publication bias for these outcomes. While our analysis does not detect substantial publication bias, due to the small number of studies, it cannot definitively rule it out. Further research and more comprehensive data collection are necessary to conclusively address the potential issue of publication bias in this field.
Discussion
This meta-analysis collected studies from current literature to determine the effectiveness of educational interventions regarding the severity of AD and quality of life. Compared to a prior meta-analysis performed in 2020, our study had no restriction on age, included interventions that featured adult participants, and performed a sub-analysis based on virtual modalities [2]. Additionally, our study included a larger study size in the quantitative analysis with up to 18 studies total compared to the 7 studies analyzed for SCORAD and 4 for quality of life in the past review.
Table 1; Fig. 2 showcase a summary of the 12 articles which used SCORAD as a metric for the impact of the intervention. Of these 12 articles, 11 articles showed a significant improvement from baseline with AD education intervention.
Muzzolon et al. examined the use of an educational workshop for pediatric patients and parents in improving the quality of life and disease severity for pediatric patients with AD. Of all the studies which used the SCORAD scoring method, this study had the largest improvement in scores. The 90-minute educational intervention consisted of two stages: one with patients accompanied by parents and another with just patients. During the meeting with the parents, they attended a lecture discussing the general aspects of AD, including pathophysiology, triggers, and treatment, followed by an open discussion regarding their personal experiences with AD. At the pediatric patients’ meeting, they participated in expressive activities such as drawing and painting about their experience living with AD. Later, they watched a puppet show which focused on the importance of care practices for managing AD and reproduced the puppet show through their drawings. Finally, they collaboratively participated in a hydration workshop on proper application of moisturizers with the hopes of increasing education and mutual support amongst the group. While most studies solely focus on parent education of AD, this study highlights the importance of providing education to both the patient and caregiver by incorporating unique educational resources relevant to each stakeholder.
Chen et al. studied the impact of educational follow-up with community health workers over a 12-week period in addition to standard clinic patient education for Hispanic patients living with AD. Of all the studies which used the SCORAD scoring method, this study had the least significant results with no difference between the control and active arm. One possible limitation in the protocol included a lack of standardization of educational protocol between the educators which may have played a role in the active arm not producing significant improvements over the control. Due to increased health disparities in Hispanic patients living with AD [21, 22], culturally competent public health interventions are vital. Prior studies in the AD educational realm have shown success when implementing cultural phenomena as part of a tailored intervention [23]. Future studies using models like community health workers should be encouraged in combination with standardized educational programming and additional forms of active learning.
Moreover, there was a large degree of heterogeneity (I2 = 81%) among the studies which used SCORAD as a scoring system for the impact of AD education on AD severity. This large degree of heterogeneity can be attributed to the various patient populations that were sampled from the different studies (pediatric patients, adult patients, and parents of pediatric patients).
Altogether, the standardized mean difference of 0.65 between all the pooled SCORAD studies suggests that educational interventions have a ‘moderate’ statistical improvement regarding changes in this specific outcome metric. In particular, the overall mean improvement was Z = 6.26 (p < 0.00001), which at first glance falls short of what is considered a minimally important change (MIC) for absolute improvements of SCORAD (8.2) [24]. An important factor to consider, however, is that the best criteria for MIC can vary based on disease severity. For example, patients with mild disease severity of score 8 or less cannot reach a statistical improvement greater than 8 regardless of reported clinical improvement [25].
Table 1; Fig. 3 summarize 7 studies that used Dermatology Life Quality Index (DLQI/QoL) as a metric for intervention effectiveness. Of the 7 articles, 5 showed statistically significant improvements in the DLQI/QoL index with the use of educational interventions. Similarly, the Patient-Oriented Eczema Measurement (POEM) is a questionnaire used to assess the severity and impact of atopic dermatitis on the daily life of patients. Table 1; Fig. 4 examine the 4 analyzed studies using POEM as a measure to determine the impact of educational interventions on AD severity. 2 of these 4 articles showed significant improvements in scores with the use of educational interventions.
In another study, Grillo et al. examined the use of a 2-hour educational workshop on the appropriate care for AD. The workshop was a practical session focusing on wet wrapping and cream application. Of the 7 studies which measured DLQI/QoL and POEM, this study had the greatest improvement. Quality of life measures were significantly improved only in the group aged 5–16 years. Furthermore, Gilliam et al. studied the use of Eczema Action Plans (EAPs) to improve parental/caregiver education on treatment and care for children with AD. This study showed the least improvement in AD severity for interventions measuring DLQI/QoL and POEM with no significant difference between the active and control arms. While EAPs and patient pamphlets might be a simple method to help patients understand eczema and adhere to medication regimens, the trend observed over the various scoring metrics illustrate that active methods of education are superior to passive learning gained through a pamphlet format, regardless of whether the pamphlet content is distributed through in-person or virtual means.
Figure 5; Table 1 display the 3 studies that used the EASI scoring system to measure the impact of atopic dermatitis educational interventions on disease severity. Notably, Singer et al. showed how the effect of daily text messages with patient education material and treatment reminders plays a significant role in reducing AD severity, as measured through EASI. Of the 3 studies we examined, this study showed the largest standard mean difference. However, the authors concluded that this pilot study did not demonstrate a significant difference in EASI scores for text message reminders as reflected by the low standard mean difference. Comparably, the study with the lowest mean in our EASI analysis had a similar overall mean. LeBovidge et al. randomized 175 caregivers into an intervention group (handbook in addition to standard AD management) and a control group (standard AD management). They did not demonstrate a great difference in EASI with a standardized mean difference of 0.79 and a 95% confidence interval of 0.48–1.10. One possible explanation for lower scores among the EASI groups could be low sample size in combination with passive forms of education (e.g. text messaging, handbooks) constituting most of the interventions within this cohort.
Most educational interventions in the literature have focused on the pediatric population, and while the pediatric population has the highest prevalence of AD, adult patients who have this diagnosis typically experience more complex forms of the disease [26–28]. Although we were unable to perform a high-powered analysis from lack of adult interventions utilizing standardized metrics compared to pediatric cohorts, our sub-analysis provided in Fig. 7 shows that there was an equal improvement in adult educational interventions when compared to pediatric populations for SCORAD outcomes. These findings suggest that targeted educational programs in understudied adult populations can be just as effective as pediatric-focused ones and should be explored further.
With the advent of the COVID-19 pandemic, the utilization of online formatting has put telehealth at the forefront. Similar interventions on a patient education level can help patients access programming that might otherwise be inaccessible due to distance, availability, or financial costs associated with attending (e.g. eczema schools located in limited urban settings). Our sub-analysis comparing in-person vs. virtual education arms outlined in Fig. 6 found no significant differences between groups. These results suggest that virtual interventions can be effective vehicles for content delivery and reducing barriers of access to patient education. More investigations using virtual interventions should be conducted to allow a higher-powered analysis.
Overall, educational interventions were shown to have significant impacts on reducing AD severity as per the SCORAD, DLQI/QoL, POEM, and EASI measurements. The studies which focused on interventions with multiple learning modalities including practical skills and collaborative learning had the greatest effect. Future studies on the impact of educational interventions should aim to incorporate various methodologies to better stimulate individual learning preferences. Research in adult cohorts and the effectiveness of virtual interventions should be further investigated.
Data availability
No datasets were generated or analysed during the current study.
References
Grossman SK, Schut C, Kupfer J, Valdes-Rodriguez R, Gieler U, Yosipovitch G (2018) Experiences with the first eczema school in the United States. Clin Dermatol 36(5):662–667. https://doi.org/10.1016/j.clindermatol.2018.05.006
Zhao M, Liang Y, Shen C, Wang Y, Ma L, Ma X (2020) Patient Education Programs in Pediatric atopic dermatitis: a systematic review of Randomized controlled trials and Meta-analysis. Dermatol Ther (Heidelb) 10(3):449–464. https://doi.org/10.1007/s13555-020-00365-z
Staab D, von Rueden U, Kehrt R et al (2002) Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol 13(2):84–90. https://doi.org/10.1034/j.1399-3038.2002.01005.x
Grillo M, Gassner L, Marshman G, Dunn S, Hudson P (2006) Pediatric atopic eczema: the impact of an educational intervention. Pediatr Dermatol 23(5):428–436. https://doi.org/10.1111/j.1525-1470.2006.00277.x
Staab D, Diepgen TL, Fartasch M et al (2006) Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 332(7547):933–938. https://doi.org/10.1136/bmj.332.7547.933
Weber MB, Fontes Neto Pde T, Prati C et al (2008) Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. J Eur Acad Dermatol Venereol 22(8):992–997. https://doi.org/10.1111/j.1468-3083.2008.02697.x
Shaw M, Morrell DS, Goldsmith LA (2008) A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD). Pediatr Dermatol 25(1):19–24. https://doi.org/10.1111/j.1525-1470.2007.00575.x
Moore EJ, Williams A, Manias E, Varigos G, Donath S (2009) Eczema workshops reduce severity of childhood atopic eczema. Australas J Dermatol 50(2):100–106. https://doi.org/10.1111/j.1440-0960.2009.00515.x
Armstrong AW, Kim RH, Idriss NZ, Larsen LN, Lio PA (2011) Online video improves clinical outcomes in adults with atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol 64(3):502–507. https://doi.org/10.1016/j.jaad.2010.01.051
Futamura M, Masuko I, Hayashi K, Ohya Y, Ito K (2013) Effects of a short-term parental education program on childhood atopic dermatitis: a randomized controlled trial. Pediatr Dermatol 30(4):438–443. https://doi.org/10.1111/pde.12105
Armstrong AW, Johnson MA, Lin S, Maverakis E, Fazel N, Liu FT (2015) Patient-centered, direct-access online care for management of atopic dermatitis: a randomized clinical trial. JAMA Dermatol 151(2):154–160. https://doi.org/10.1001/jamadermatol.2014.2299
Pustišek N, Šitum M, Vurnek Živković M, Ljubojević Hadžavdić S, Vurnek M, Niseteo T (2016) The significance of structured parental educational intervention on childhood atopic dermatitis: a randomized controlled trial. J Eur Acad Dermatol Venereol 30(5):806–812. https://doi.org/10.1111/jdv.13519
Gilliam AE, Madden N, Sendowski M, Mioduszewski M, Duderstadt KG (2016) Use of Eczema Action Plans (EAPs) to improve parental understanding of treatment regimens in pediatric atopic dermatitis (AD): a randomized controlled trial. J Am Acad Dermatol 74(2):375–7e73. https://doi.org/10.1016/j.jaad.2015.08.067
Heratizadeh A, Werfel T, Wollenberg A et al (2017) Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial. J Allergy Clin Immunol 140(3):845–853e3. https://doi.org/10.1016/j.jaci.2017.01.029
Liang Y, Tian J, Shen CP et al (2018) Therapeutic patient education in children with moderate to severe atopic dermatitis: a multicenter randomized controlled trial in China. Pediatr Dermatol 35(1):70–75. https://doi.org/10.1111/pde.13362
Cheng NS, Chun Chau JP, Lun Hon EK et al (2020) A nurse-led parental Eczema Education Programme on Chinese Parents of Children with Eczema: a Randomised Controlled Trial. J Allergy Clin Immunol 145(2):AB347. https://doi.org/10.1016/j.jaci.2019.12.097
Muzzolon M, Imoto RR, Canato M, Abagge KT, de Carvalho VO (2021) Educational intervention and atopic dermatitis: impact on quality of life and treatment. Asia Pac Allergy 11(2):e21 Published 2021 Apr 26. https://doi.org/10.5415/apallergy.2021.11.e21
LeBovidge JS, Timmons K, Delano S et al (2021) Improving patient education for atopic dermatitis: a randomized controlled trial of a caregiver handbook. Pediatr Dermatol 38(2):396–404. https://doi.org/10.1111/pde.14519
Santer M, Muller I, Becque T et al (2022) Eczema Care Online behavioural interventions to support self-care for children and young people: two independent, pragmatic, randomised controlled trials. BMJ 379:e072007 Published 2022 Dec 7. https://doi.org/10.1136/bmj-2022-072007
Chen HW, Limmer EE, Joseph AK et al (2023) Efficacy of a lay community health worker (promotoras de salud) program to improve adherence to emollients in spanish-speaking Latin American pediatric patients in the United States with atopic dermatitis: a randomized, controlled, evaluator-blinded study. Pediatr Dermatol 40(1):69–77. https://doi.org/10.1111/pde.15148
Singer HM, Levin LE, Morel KD, Garzon MC, Stockwell MS, Lauren CT. Texting atopic dermatitis patients to optimize learning and eczema area and severity index scores: a pilot randomized control trial. Pediatr Dermatol. 2018;35(4):453–457. https://doi.org/10.1111/pde.13510.
Hedman-Lagerlöf E, Fust J, Axelsson E, et al. Internet-Delivered Cognitive Behavior Therapy for Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol. 2021;157(7):796–804.https://doi.org/10.1001/jamadermatol.2021.1450
Choragudi S, Andrade LF, Silverberg J, Yosipovitch G (2023) Dermatitis. https://doi.org/10.1089/derm.2023.0008. Trends in Health Care Utilization Among United States Children With Eczema by Age, Sex, Race, and Hispanic Ethnicity: National Health Interview Survey 2006–2018 [published online ahead of print, 2023 Apr 25]
Wan J, Oganisian A, Spieker AJ et al (2019) Racial/Ethnic variation in Use of Ambulatory and Emergency Care for atopic dermatitis among US children. J Invest Dermatol 139(9):1906–1913e1. https://doi.org/10.1016/j.jid.2019.02.024
Andrade LF, Bekhash M, Choragudi S, Gonzalez JM, Valdes R, Yosipovitch G (2023) Impact of a Digital Atopic Dermatitis Educational Intervention on hispanic patients and family members. J Clin Med 12(6):2130 Published 2023 Mar 8. https://doi.org/10.3390/jcm12062130
Schram ME, Spuls PI, Leeflang MM et al (2012) EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy ; 67: 99–106
Silverberg JI, Lei D, Yousaf M et al (2021) What are the best endpoints for Eczema Area and Severity Index and Scoring atopic dermatitis in clinical practice? A prospective observational study. Br J Dermatol 184(5):888–895. https://doi.org/10.1111/bjd.19457
Angles MV, Antonietti CA, Torre AC, Juszkiewicz Franzé E, Mazzuoccolo LD, Parisi CAS (2022) Prevalence of atopic dermatitis in adults. Bras Dermatol 97(1):107–109. https://doi.org/10.1016/j.abd.2020.10.016
Funding
There are no funding sources.
Author information
Authors and Affiliations
Contributions
L.A. and P.A. conceived the study. Material preparation, abstract screening, and data extraction were performed by K.M., A.K., A.E., R.U., and A.S. Data analysis was performed by L.A. and P.A. The first draft of the manuscript was written by L.A., P.A., and K.M. The final version of the manuscript was prepared by K.M. G.Y. commented on previous versions of the manuscript and reviewed the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Conflicts of interest for Dr. Gil Yosipovitch include: Consultant And Board member Sanofi, Regeneron, Pfizer, Galderma, Novartis, Eli Lilly, Abbvie, Kiniksa, Trevi, Pierre Gabre, LEo, Escient. Celldex, Bellus, Research support Pfizer, Sanofi Regeneron, Leo, Eli Lilly, Kiniksa, Novartis, Escient, Bellus , Galderma, Celldex.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Andrade, L.F., Abdi, P., Mashoudy, K.D. et al. Effectiveness of atopic dermatitis patient education programs – a systematic review and meta-analysis. Arch Dermatol Res 316, 135 (2024). https://doi.org/10.1007/s00403-024-02871-y
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00403-024-02871-y